Idiopathic Gastroparesis clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
open to eligible people ages 18-70
To investigate the safety and efficacy of tradipitant versus placebo in relieving nausea and other symptoms of gastroparesis.
at UCSD
Our lead scientists for Idiopathic Gastroparesis research studies include David Kunkel.
Last updated: